CYP2D6 genotyping in a Korean cohort: comparative analysis with Asian, Caucasian, and African populations
This is the largest study of CYP2D6 polymorphisms in a Korean population to date. It provides a comprehensive reference for Korean pharmacogenomics and highlights important interethnic differences. The findings support the development of personalized medicine strategies based on population-specific pharmacogenetic data.
Authors
- Ji Hye Song (ORCID: https://orcid.org/0000-0002-3952-5096)
- Jae‐Gook Shin (ORCID: https://orcid.org/0000-0002-5821-850X)
- Seol Ju Moon (ORCID: https://orcid.org/0000-0001-6484-2029)
- Jin‐Hwan Kwak (ORCID: https://orcid.org/0000-0003-3613-5380)
- Young‐Ran Yoon (ORCID: https://orcid.org/0000-0003-2166-7579)
- Ho-Sook Kim (ORCID: https://orcid.org/0000-0001-6764-7261)
- Chan Song Park
- Min‐Gul Kim (ORCID: https://orcid.org/0000-0001-7269-9533)
- Tak Don Kim
- Jang Hee Hong (ORCID: https://orcid.org/0000-0002-0623-5455)
- Mi‐Ri Gwon (ORCID: https://orcid.org/0000-0001-5703-1615)
- SeungHwan Lee (ORCID: https://orcid.org/0000-0002-1713-9194)
- Jung Sunwoo (ORCID: https://orcid.org/0000-0001-8801-0323)
Institutions
- Inje University (KR)
- Seoul National University (KR)
- Chungnam National University (KR)
- Kyungpook National University Hospital (KR)
- New Generation University College (ET)
- Seoul National University Hospital (KR)
- National University College (PR)
- Jeonbuk National University Hospital (KR)
- Science Factory (US)
- Chungnam National University Hospital (KR)
- SP Technology (South Korea) (KR)
- Jeonbuk National University (KR)
Publication Details
- Journal
- Pharmacogenomics
- Published
- 2025-08-13
- DOI
- https://doi.org/10.1080/14622416.2025.2565993
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00